🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Huge thanks from the Cardior Pharmaceuticals - a Novo Nordisk company team to all of you, our partners and friends, for your heartfelt congratulations on the potential acquisition by Novo Nordisk. It’s an important step towards bringing #RNA-based therapies to heart failure patients! More cardior.de/media/

On Wednesday April 17 Thomas Thum, Professor of @MHH_life and Cardior Pharmaceuticals - a Novo Nordisk company's CSO/CMO is holding a presentation on the development of noncoding #RNA therapeutics for #CDV at Keystone Symposia Cardiovascular Epigenetics and Gene Regulation. Learn more: keystonesymposia.org/conferences/co…

Cardior Pharmaceuticals - a Novo Nordisk company's CEO Dr. Claudia Ulbrich is participating in German Biotech Days 2024 taking place in Berlin on April 16-17. It is the best place to feel the pulse of German biotech and a perfect meeting point for science and business.

As of May 2, 2024 Cardior Pharmaceuticals - a Novo Nordisk company has become a fully owned subsidiary of Novo Nordisk. Happy to combine forces with Novo Nordisk to accelerate the clinical development of our lead compound with the aim of bringing life-saving treatment to heart patients! Two teams in Hannover.

Here’s a teaser to a new episode from Hannover 🇩🇪 with Claudia Ulbrich, CEO and co-founder of Cardior Pharmaceuticals - a Novo Nordisk company. Hear the details about Cardior’s recent €1B exit to Novo Nordisk, miRNA/Cardiovascular and more. Watch on YouTube, Spotify or Apple. What do you think? 🤔

Watch our CEO, Claudia Ulbrich, in the @Flotbio podcast where she discussed the recent €1B acquisition of Cardior by Novo Nordisk . The episode is a deep dive into Cardior Pharmaceuticals - a Novo Nordisk company story and acquisition and the inspiring career of Dr. Claudia Ulbrich: youtube.com/watch?v=yxCw5R…

Cardior’s founder and CSO/CMO Prof. Thomas Thum will present the exciting journey starting from research on #microRNAs at the bench to clinical testing in heart failure and the potential of #CDR132L to tackle the root causes of acute and chronic HF: escardio.org/Congresses-Eve…

Cardior Pharmaceuticals - a Novo Nordisk company CEO Dr. Claudia Ulbrich is participating in demi colton Biotech CEO Summit Europe in Barcelona, Spain on May 27-29, 2024. On Monday May 27 Claudia is invited to speak at Fireside Chat moderated by PKO of Blue Matter. To learn more: biotechceosummit-eu.com/2024-program/

We are happy to announce Thomas Thum and Dr. Claudia Ulbrich are among the finalists of Andreas & Thomas Struengmann Award, the first of its kind in the DACH region aimed at recognizing entrepreneurial achievements in the life sciences arena: businesswire.com/news/home/2024…

We congratulate Vicente Godoy on the promotion to Vice President Quality Management & Compliance and welcome him to Cardior Pharmaceuticals - a Novo Nordisk company Leadership Team!

Dr. Sandor Batkai, Cardior Pharmaceuticals - a Novo Nordisk company's Co-founder & Head of Medical Research and Intelligence, is presenting at the 3rd Annual Heart Failure Drug Discovery & Development Summit in Boston, MA on Aug 1, 2024. Check the agenda for more and stop by: heartfailuresummit.com

Cardior Pharmaceuticals’ CEO and Co-Founder Dr. Claudia Ulbrich is in Oslo this week to take part in Hadean Investment Event 2024 organized by #Hadeanventures held in the world famous #Munchmuseeum on October 23-24.

We are excited that Cardior Pharmaceuticals' CEO and Co-Founder Dr. Claudia Ulbrich is invited to speak at BioMed Life Science Day organized by BioMed Partners in Basel, Switzerland on October 31, 2024.

Our CEO, Dr. Claudia Ulbrich, and CSO/CMO Dr. Thomas Thum will be engaging in key discussions on the future of healthcare with global leaders across the industry. If you're attending, let’s connect! #FallingWalls #ScienceSummit24

Our CEO, Claudia Ulbrich will join a panel at HQ Trust Investors Forum 2024 during Euro Finance Week. She’ll share insights on Cardior’s recent acquisition by Novo Nordisk as an example of adding impact to returns for investing into innovation. #EuroFinanceWeek #HQTrustForum

Our CEO, Claudia Ulbrich , will attend the 34th Frankfurt European Banking Congress, where she will join experts across different sectors in exploring Europe’s role in the global landscape. Reach out if you are also attending and want to connect! #EuropeanBankingCongress

Earlier this month, Claudia Ulbrich moderated the panel “Biomedical Innovation Ecosystems: Recipes for Success” at the Falling Walls Science Summit 2024, to discuss how collaboration, cutting-edge research, and strategic investment are driving breakthroughs in #LifeSciences

Our CSO/CMO and Founder Thomas Thum will attend the #CVCT Forum 2024 in Washington DC, bringing together global cardiovascular experts and key stakeholders. Looking forward to insightful presentations and discussions! #cvct2024 #clinicalresearch #clinicaltrials

Proud to announce that our CEO and Co-Founder, Claudia Ulbrich has been named one of “Deutschlands 30 bis 2030” by WirtschaftsWoche: wiwo.de/technologie/fo… Looking forward to connecting with pioneering minds from Germany at the #HMGWinterCamp in Düsseldorf.

Last night, our CEO Claudia Ulbrich was recognized by WirtschaftsWoche as one of Germany’s 30 by 2030, driving innovation in Germany as serial biotech entrepreneur! Join us in congratulating Claudia and access the recording here: linkedin.com/video/live/urn…